PAHO urges Americas to intensify measles response as outbreaks threaten elimination

As of 13 November 2026, the Americas had reported 58,213 confirmed measles cases and 82 deaths, compared with 12,806 cases during the same period in 2025.

USA—The Pan American Health Organization (PAHO) has urged countries across the Americas to strengthen vaccination and disease surveillance in November 2026 as rising measles infections threaten progress towards regional elimination.

The call follows a 10 to 13 November meeting of the Measles, Rubella and Congenital Rubella Syndrome Elimination Regional Monitoring and Re-Verification Commission (RVC), which confirmed that endemic measles transmission had been re-established in Bolivia, Mexico and the United States.

The three countries have consequently lost their measles elimination status after the same virus lineage circulated continuously for at least 12 months.

PAHO Director Dr. Jarbas Barbosa accepted the Commission’s assessment, warning that prolonged transmission increases the risk of preventable infections, hospitalisations and deaths.

Rising cases undermine regional progress

As of 13 November 2026, the Americas had reported 58,213 confirmed measles cases and 82 deaths, compared with 12,806 cases during the same period in 2025.

The Region regained measles elimination status in 2024 after interrupting endemic transmission in Venezuela and Brazil.

However, it lost its regional status in November 2025 following sustained transmission in Canada.

Although Canada has since interrupted the transmission chain associated with the outbreak, Bolivia, Mexico and the United States have also lost their individual elimination status.

The resurgence reflects persistent vaccination gaps, particularly in vulnerable communities where limited access to healthcare, missed immunisations and vaccine misinformation undermine population immunity.

Measles is highly contagious, with one infected person capable of transmitting the virus to up to 18 susceptible individuals.

Complications include pneumonia, encephalitis and blindness, while infection can also weaken the immune system for months.

Protecting infants too young to receive vaccination and people who cannot be immunised for medical reasons depends on maintaining high community immunity.

PAHO prioritises vaccination and surveillance

The RVC has recommended that countries use PAHO’s risk assessment tools to identify underserved populations, strengthen active case detection and improve laboratory investigations.

It also called for tailored outbreak response plans, healthcare worker protection and timely allocation of operational resources.

PAHO is supporting national health authorities through vaccination campaigns, epidemiological and laboratory surveillance, rapid-response teams and outbreak investigations.

Countries are also encouraged to use the organisation’s July 2026 Measles Preparedness and Response Matrix to guide interventions.

Maintaining at least 95% coverage with both doses of the measles vaccine in every community remains central to interrupting transmission.

However, national coverage averages can conceal localised immunity gaps, requiring more targeted immunisation programmes.

For healthcare systems, the renewed outbreaks increase pressure on vaccine procurement, laboratory capacity, disease surveillance and emergency response infrastructure.

 Sustained investment in immunisation programmes and last-mile vaccine delivery will therefore remain important to preventing further transmission.

“Elimination is not a trophy that we win once and put on a shelf. It must be protected every day by closing immunity gaps and ensuring that every community is reached,” Dr. Barbosa said.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.

Visited 4 times, 4 visit(s) today

Newer Post

Thumbnail for PAHO urges Americas to intensify measles response as outbreaks threaten elimination

Sanner set to debut expanded medical device, pharma packaging capabilities at Pharmapack 2027

Older Post

Thumbnail for PAHO urges Americas to intensify measles response as outbreaks threaten elimination

Novo secures EU approval for FREHEMGO in haemophilia A

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *